Common Stock, Shares, Outstanding of Fulcrum Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Fulcrum Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Fulcrum Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 66,578,891, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Fulcrum Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 66,578,891 +12,610,588 +23% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 54,108,438 +169,777 +0.32% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 54,091,588 -8,159,043 -13% 30 Jun 2025 10-Q 29 Jul 2025 2025 Q2
Q1 2025 53,979,306 -8,161,705 -13% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 53,968,303 -7,947,064 -13% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 53,938,661 +1,839,450 +3.5% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 62,250,631 +10,151,420 +19% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 62,141,011 +382,017 +0.62% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 61,915,367 +9,816,156 +19% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 52,099,211 +49,298 +0.1% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 52,099,211 +11,091,006 +27% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q1
Q1 2023 61,758,994 +21,075,389 +52% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 52,099,211 +11,472,987 +28% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 52,049,913 +11,523,928 +28% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 41,008,205 +8,348,465 +26% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 40,683,605 +8,089,169 +25% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 40,626,224 +12,684,658 +45% 31 Dec 2021 10-K/A 26 Jun 2023 2022 FY
Q3 2021 40,525,985 +13,248,002 +49% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 32,659,740 +5,435,944 +20% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 32,594,436 +9,801,299 +43% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 27,941,566 +5,287,122 +23% 31 Dec 2020 10-K/A 26 Jun 2023 2021 FY
Q3 2020 27,277,983 +4,720,112 +21% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 27,223,796 +25,353,510 +1356% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 22,793,137 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 22,654,444 +21,066,491 +1327% 31 Dec 2019 10-K/A 23 Jun 2023 2020 FY
Q3 2019 22,557,871 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 1,870,286 30 Jun 2019 10-Q 26 Aug 2019 2019 Q2
Q4 2018 1,587,953 31 Dec 2018 10-K 05 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.